Last updated:
7/18/2025
Years published: 1996, 2003, 2016, 2019, 2023, 2025
NORD gratefully acknowledges Gioconda Alyea, MD (FMG), MS, National Organization for Rare Disorders and Dr. Charlotte Ockeloen, Clinical Geneticist, Clinical Pharmacologist, Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands, for her assistance in updating this report.
KBG syndrome (KBGS) is a rare genetic disorder characterized by large front teeth (macrodontia), characteristic facial features, short to normal stature, developmental delay and intellectual disability. The level of intellectual disability is usually mild, and there are people with KBGS who have normal intelligence. Behavioral issues are common. People with KBGS can have skeletal abnormalities (such as short fingers, delayed closure of the fontanelle or scoliosis), hearing loss and feeding difficulties (particularly in infancy) and some have epilepsy (seizures) or brain malformations. The specific symptoms may vary from one person to another.
KBG syndrome is caused by a change (variant) in the ANKRD11 gene or a loss of genetic material (microdeletion) on chromosome 16q that involves the ANKRD11 gene. Variants of this gene can occur spontaneously (de novo) with no family history or can be inherited in an autosomal dominant manner.
Treatment is directed toward the specific symptoms that an affected person has.
KBG syndrome is named after the initials of the last names of the first three families identified with this disorder in the medical literature in 1975.
People with KBG syndrome usually present with skeletal abnormalities, distinct facial features and intellectual delays. The following signs and symptoms may be present in people with KBG syndrome:
Less commonly, additional findings have been reported in some children including:
KBG syndrome is caused by either a change (variant) in the ANKRD11 gene or a loss of genetic material from chromosome 16q that includes the ANKRD11 gene. Genes provide instructions for creating proteins that play a critical role in many functions of the body. When a variant of a gene occurs, the protein product may be faulty, inefficient, or absent. Depending upon the functions of the protein, this can affect many organ systems of the body.
The ANKRD11 gene contains instructions for creating a protein that is active in nerve cells (neurons). The exact role of this protein is not fully understood. When the ANKRD11 gene is altered or missing, the person cannot produce enough functional copies of this protein. More research is necessary to determine how low levels of the protein product of the ANKRD11 gene cause the symptoms of KBG syndrome.
KBG syndrome is inherited in an autosomal dominant pattern. Dominant genetic disorders occur when only a single copy of a disease-causing gene variant is necessary to cause the disease. The gene variant can be inherited from either parent or can be the result of a new (de novo) changed gene in the affected individual that is not inherited. The risk of passing the gene variant from an affected parent to a child is 50% for each pregnancy. The risk is the same for males and females.
KBG syndrome is a rare disorder that affects males and females. As of 2023, around 400 cases have been reported in the medical literature. The actual number of patients worldwide is believed to be much higher. It is projected that the number of patients with ANKRD11 variants exceeds 800. The disorder can go undiagnosed or misdiagnosed, making it difficult to determine the true frequency of KBG syndrome in the general population.
A diagnosis of KBG syndrome may be suspected after a thorough clinical evaluation, a detailed patient and family history, and the identification of characteristic physical findings. Diagnosis should be suspected in children who have the distinctive craniofacial features, short stature, developmental delay, intellectual disability and epilepsy. The diagnosis can be confirmed with genetic testing identifying a ANKRD11 variant.
Treatment is directed toward the specific symptoms that are apparent in each individual. Treatment may require the coordinated efforts of a team of specialists. Pediatricians, orthopedists, orthopedic surgeons, (pediatric) neurologists, physical therapists, speech therapists, orthodontists or dentists and other healthcare professionals may need to plan an affected child’s treatment systematically and comprehensively.
Genetic counseling is recommended for affected individuals and their families. Psychosocial support for the entire family may be beneficial as well.
Orthopedic surgery may be particularly helpful to correct hip and spine abnormalities. Hearing aids, speech therapy and comprehensive dental care may also be beneficial.
Some children with KBG syndrome have been treated with growth hormone therapy. Initial results have been promising in helping children who are experiencing growth delays or diminished growth. More research is necessary to determine the long-term safety and effectiveness of growth hormone therapy in children with KBG syndrome.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Toll-free: (800) 411-1222
TTY: (866) 411-1010
Email: [email protected]
Some current clinical trials also are posted on the following page on the NORD website:
https://rarediseases.org/for-patients-and-families/information-resources/info-clinical-trials-and-research-studies/
For information about clinical trials sponsored by private sources, contact:
www.centerwatch.com
For more information about clinical trials conducted in Europe, contact: https://www.clinicaltrialsregister.eu/
TEXTBOOKS
Dowling PA, Fleming P, Gorlin RJ. KBG Syndrome. In: NORD Guide to Rare Disorders. Lippincott Williams & Wilkins. Philadelphia, PA. 2003:210.
JOURNAL ARTICLES
Serra G, Elefante P, Gazzitano Y, et al. KBG syndrome: report and follow-up on three unrelated patients observed at different ages. Ital J Pediatr. 2025;51(1):54. Published 2025 Feb 21. doi:10.1186/s13052-025-01884-1
He D, Zhang M, Li Y, Liu F, Ban B. Insights into the ANKRD11 variants and short-stature phenotype through literature review and ClinVar database search. Orphanet J Rare Dis. 2024;19(1):292. Published 2024 Aug 12. doi:10.1186/s13023-024-03301-y
Hills S, Pugacheva A, Weltin P, et al. Tethered cord syndrome in KBG syndrome. Am J Med Genet A. 2023;191(5):1222-1226. doi:10.1002/ajmg.a.63128
Martinez-Cayuelas E, Blanco-Kelly F, Lopez-Grondona F, et al. Clinical description, molecular delineation and genotype-phenotype correlation in 340 patients with KBG syndrome: addition of 67 new patients. J Med Genet. 2023;60(7):644-654. doi:10.1136/jmg-2022-108632
Peluso F, Caraffi SG, Contrò G, et al. Deep phenotyping of the neuroimaging and skeletal features in KBG syndrome: a study of 53 patients and review of the literature. J Med Genet. 2023;60(12):1224-1234. Published 2023 Nov 27. doi:10.1136/jmg-2023-109141
Ge XY, Ge L, Hu WW, Li XL, Hu YY. Growth hormone therapy for children with KBG syndrome: A case report and review of literature. World J Clin Cases. 2020;8(6):1172-1179. doi:10.12998/wjcc.v8.i6.1172
Low K, Ashraf T, Canham N, et al. Clinical and genetic aspects of KBG syndrome. Am J Med Genet A. 2016;170(11):2835-2846. doi:10.1002/ajmg.a.37842
Goldenberg A, Riccardi F, Tessier A, et al. Clinical and molecular findings in 39 patients with KBG syndrome caused by deletion or mutation of ANKRD11. Am J Med Genet A. 2016;170(11):2847-2859. doi:10.1002/ajmg.a.37878
Ockeloen CW, Willemsen MH, de Munnik S, et al. Further delineation of the KBG syndrome caused by ANKRD11 aberrations. Eur J Hum Genet. 2015;23:1270. https://www.ncbi.nlm.nih.gov/pubmed/26269249
Reynaert N, Ockeloen CW, Savedahl L, et al. Short stature in KBG syndrome: first responses to growth hormone treatment. Horm Res Paediatr. 2015;83:361-364. https://www.ncbi.nlm.nih.gov/pubmed/25833229
Sacharow S, Li D, Fan YS, Tekin M. Familial 16q24.3 microdeletion involving ANKRD11 causes a KBG-like syndrome. Am J Med Genet A. 2012;158A(3):547-552. doi:10.1002/ajmg.a.34436
Sirmaci A, Spiliopoulos M, Brancati F, et al. Mutations in ANKRD11 cause KBG syndrome, characterized by intellectual disability, skeletal malformations, and macrodontia. Am J Hum Genet. 2011;89:289-294. https://www.ncbi.nlm.nih.gov/pubmed/21782149
Almandey AH, Anthonappa RP, King NM, Fung CW. KBG syndrome: clinical features and specific dental findings. Pediatr Dent. 2010;32:439-444. https://www.ncbi.nlm.nih.gov/pubmed/21070713
Brancati F, Sarkozy A, Dallapiccola B. KBG syndrome. Orphanet J Rare Dis. 2006;1:50. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1764006/
Tekin M, Kavaz A, Berberoglu M, et al. The KBG syndrome: confirmation of autosomal dominant inheritance and further delineation of the phenotype. Am J Med Genet A. 2004;130A:284-287. https://www.ncbi.nlm.nih.gov/pubmed/15378538
Dowling PA, Fleming P, Gorlin RG, et al. The KBG syndrome, characteristic dental findings: a case report. Int J Paediatr Dent. 2001;11:131-34. https://www.ncbi.nlm.nih.gov/pubmed/11310136
Mathieu M, Helou M, Morin G, et al. The KBG syndrome: an additional sporadic case. Genet Couns. 2000;11:33-35. https://www.ncbi.nlm.nih.gov/pubmed/10756425
Soekarman D, Volcke P, Fryns JP. The KBG syndrome: follow-up data on three affected brothers. Clin Genet. 1994;46:283-86. https://www.ncbi.nlm.nih.gov/pubmed/7834892
Zollarion M, Battaglia A, D’Avanzo MG, et al. Six additional cases of the KBG syndrome: clinical reports and outline of the diagnostic criteria. Am J Med Genet. 1994;52:302-07. https://www.ncbi.nlm.nih.gov/pubmed/7810561
Fryns JP, Haspeslagh M. Mental retardation, short stature, minor skeletal anomalies, craniofacial dysmorphism and macrodontia in two sisters and their mother. Another variant example of KBG syndrome? Clin Genet. 1984;26:69-72. https://www.ncbi.nlm.nih.gov/pubmed/6467660
Hermann J, Pallister PD, Tiddy W, Optiz JM. The KBG syndrome – a syndrome of short stature, characteristic facies, mental retardation, macrodontia and skeletal anomalies. Birth Defects. 1975;11:7-18. https://www.ncbi.nlm.nih.gov/pubmed/1218237
INTERNET
McKusick VA., ed. Online Mendelian Inheritance in Man (OMIM). Baltimore. MD: Johns Hopkins University; Entry No:148050; Last Update: 10/11/2023. Available at: https://omim.org/entry/148050 Accessed June 25, 2025.
KBG Syndrome. Orphanet. September 2020. Available at: https://www.orpha.net/consor/cgi-bin/OC_Exp.php?Expert=2332 Accessed June 25, 2025.
KBG Syndrome. MedlinePlus. January 1, 2018. Available at: https://medlineplus.gov/genetics/condition/kbg-syndrome/ Accessed June 25, 2025.

NORD strives to open new assistance programs as funding allows. If we don’t have a program for you now, please continue to check back with us.
NORD and MedicAlert Foundation have teamed up on a new program to provide protection to rare disease patients in emergency situations.
Learn more https://rarediseases.org/patient-assistance-programs/medicalert-assistance-program/Ensuring that patients and caregivers are armed with the tools they need to live their best lives while managing their rare condition is a vital part of NORD’s mission.
Learn more https://rarediseases.org/patient-assistance-programs/rare-disease-educational-support/This first-of-its-kind assistance program is designed for caregivers of a child or adult diagnosed with a rare disorder.
Learn more https://rarediseases.org/patient-assistance-programs/caregiver-respite/The information provided on this page is for informational purposes only. The National Organization for Rare Disorders (NORD) does not endorse the information presented. The content has been gathered in partnership with the MONDO Disease Ontology. Please consult with a healthcare professional for medical advice and treatment.
The Genetic and Rare Diseases Information Center (GARD) has information and resources for patients, caregivers, and families that may be helpful before and after diagnosis of this condition. GARD is a program of the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH).
View reportOrphanet has a summary about this condition that may include information on the diagnosis, care, and treatment as well as other resources. Some of the information and resources are available in languages other than English. The summary may include medical terms, so we encourage you to share and discuss this information with your doctor. Orphanet is the French National Institute for Health and Medical Research and the Health Programme of the European Union.
View reportOnline Mendelian Inheritance In Man (OMIM) has a summary of published research about this condition and includes references from the medical literature. The summary contains medical and scientific terms, so we encourage you to share and discuss this information with your doctor. OMIM is authored and edited at the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine.
View reportGeneReviews has an article on this condition covering diagnosis, management, and inheritance. Each article is written by one or more experts on the specific disease and is reviewed by other specialists. The article contains medical and scientific terms, so we encourage you to share and discuss this information with your doctor. The GeneReviews database is managed by the University of Washington.
View reportMedlinePlus has information about this condition that may include a description, frequency, causes, inheritance, and links to more information. The information is written for the public, including patients, caregivers and families. MedlinePlus is a service of the National Library of Medicine (NLM), which is part of the National Institutes of Health (NIH).
View reportPlease complete this form to access the requested resource.